Patent & IP news for August 10, 2014

Patent Litigations

  • No new litigations this day!



Patent & IP Blogs

"Patent or perish" and the story of "Gorilla glass" from

An article Patent or perish? Jeers greet proposal to tie Australia's academic science funding to patents describes largely negative reactions to a proposal made by Ian Macfarlane for
"rewarding them [block grants] to universities ...

Share via E–mail | Twitter | Facebook

Tariffs 22.D.1 and 22.D.2 – A free preview of what’s to come for SOCAN from

On July 18, 2014, the world of everyone who streams music or videos containing music – that is, almost everyone who uses the internet – changed a little bit. On that date, the Copyright Board released a ...

Share via E–mail | Twitter | Facebook

White House Seeks Input on Innovation Strategies from

A request for input was published on July 29, and is available here.  The summary states: The Office of Science and Technology Policy and the National Economic Council request public comments to provide input into ...

Share via E–mail | Twitter | Facebook

Telework: How much did you work? Nobody Knows! from

By Dennis Crouch In another bombshell for the Patent Office, the Washington Post has published a 2012 internal USPTO memorandum on telework fraud. Lisa Rein from the post writes: Some of the 8,300 patent ...

Share via E–mail | Twitter | Facebook

Conference & CLE Calendar from

August 13-15, 2014 - Advanced Patent Law Seminars (Chisum Patent Academy) - Seattle, WA August 18-19, 2014 - Advanced Patent Prosecution Workshop 2014: Claim Drafting & Amendment Writing (Practising Law Institute) - San Francisco, CA August 18-20, 2014 - Advanced Patent ...

Share via E–mail | Twitter | Facebook

Court Report from

By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Glycobiosciences Inc. v. Dara Biosciences, Inc. et al. 1:14-cv-01281; filed July 28, 2014 in the ...

Share via E–mail | Twitter | Facebook

Federal Circuit Revives Mutual's Antitrust Counterclaims Arising From Temazepam ANDA Litigation from

Tyco Healthcare Group et al. v. Mutual Pharm. et al., No. 2013-1386 (Fed. Cir.) by Aaron F. Barkoff In 2006, Mutual filed an ANDA for a generic version of Restoril (temazepam), including a paragraph IV ...

Share via E–mail | Twitter | Facebook

Some content © 2007–2014 RPX Corporation.
Terms of Service & Privacy Policy
For DMCA requests contact